Schedule 13D ownership disclosure
ADDEX THERAPEUTICS LTD
Security class unavailable · CUSIP: 00654J107
Event date: 2023-04-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-23-000298
- Form type
- SC 13D
- Filer
- Addex Therapeutics Ltd.
- CIK
- CIK 1574232
- Filed
- Apr 10, 2023
- Reporting period
- Apr 04, 2023
- Description
- Schedule 13D beneficial ownership